Search this site
Embedded Files
Skip to main content
Skip to navigation
Vitalex Biosciences
ABOUT VITALEX
OUR TEAM
PIPELINE
MARKET OPPORTUNITY
MEDIA
FCOI POLICY
CONTACT
Vitalex Biosciences
ABOUT VITALEX
OUR TEAM
PIPELINE
MARKET OPPORTUNITY
MEDIA
FCOI POLICY
CONTACT
More
ABOUT VITALEX
OUR TEAM
PIPELINE
MARKET OPPORTUNITY
MEDIA
FCOI POLICY
CONTACT
MEDIA
Media Gallery
Researchers report new treatment for mucormycosis, the deadly 'black fungus'
The Lundquist Institute spinoff start-up company Vitalex Biosciences, founded by researcher Dr. Ashraf Ibrahim, is producing an antibody that stems the spread of mucormycosis, a deadly fungal infection with an overall mortality rate of 50% and higher. Mucormycosis is an emerging infection caused by exposure to mucor, a mold commonly found in soil, plants, manure and decaying fruits and vegetables. It affects the sinuses, the brain and the lungs and is life-threatening in diabetic or severely immunocompromised individuals such as cancer patients. Mortality is greater than 50% and extremely disfiguring surgery is often needed to remove necrotic tissues.
Lundquist Institute Start-Up Vitalex Biosciences Awarded Grant from NIAID/NIH
Award is for the VX-01 monoclonal antibody (mAb) program targeting the debilitating indication of mucormycosisLos Angeles, April 25, 2023 (GLOBE NEWSWIRE) -- The Lundquist Institute (TLI) start-up company, Vitalex Biosciences, has been awarded an SBIR Phase 2 grant from the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health. The grant is for Vitalex’s VX-01, a monoclonal antibody (mAB) program targeting the debilitating indication of the fungal dis
Lundquist Institute Start-Up Vitalex Biosciences Awarded Grant from NIAID/NIH
Award is for the VX-01 monoclonal antibody (mAb) program targeting the debilitating indication of mucormycosis...
Baking soda may prevent fungal infection in DKA
In patients with diabetic ketoacidosis suspected of having mucormycosis, sodium bicarbonate therapy could halt the growth of the fungus and prevent the spread of infection, recent study findings show. “DKA patients suspected of having mucormycosis are likely to benefit from reversing their acidosis by the use of sodium bicarbonate (in addition to the current use of insulin injection)
Vaccine Trial Shows Promise Against Candida Fungal Infection
Although relatively rare, C. auris infections can lead to death for between 30% to 70% of those at higher risk.
Discovering Biotech Startups: A map for Selling to Vitalex Biosciences
In this edition of Discovering Biotech Startups, we're looking at the emerging California stealth biotech, Vitalex Biosciences
Report abuse
Page details
Page updated
Report abuse